Arm Holdings closed at $260.01 on Friday, July 24, 2026, down 8.14% on the session, and sitting roughly 43% below its 52-week high of $452.70. The stock is still up meaningfully over the past year, but the correction from peak has been sharp and the valuation debate has gotten louder with every pullback.
Wednesday after the close, Arm reports Q1 fiscal 2027 results. This is the report traders have been circling on the calendar. Not because the growth is in question — it almost certainly isn’t — but because the two harder questions underneath the growth are finally reaching a point where the data has to answer them.
Where the Business Actually Stands
Fiscal year 2026, which ended March 31, was Arm’s third consecutive year of more than 20% revenue growth. Total revenue reached a record $4.92 billion, up 23% year-over-year. Royalty revenue specifically hit $2.61 billion for the full year. License and other revenue reached $2.31 billion.
The Q4 quarter was particularly strong. Revenue hit $1.49 billion, up 20% year-over-year. License and other revenue jumped 29% to $819 million. Non-GAAP EPS reached $0.60, a company record. And data center royalty revenue more than doubled year-over-year for the quarter — a number CEO Rene Haas specifically called out, saying royalties associated with Neoverse-based chips doubled year-over-year and he expects them to double again in fiscal 2027.
For Q1 fiscal 2027, management guided revenue of $1.26 billion, plus or minus $50 million. The midpoint implies roughly 20% year-over-year growth. Non-GAAP EPS guidance is $0.40, plus or minus $0.04.
The Arm AGI CPU Is the Variable Nobody Can Model Cleanly
This is where it gets interesting. Arm launched the Arm AGI CPU — its first Arm-designed data center CPU for agentic AI infrastructure — in late March. Management has said it now has line of sight to more than $2 billion of demand across fiscal 2027 and fiscal 2028.
What investors are really getting this quarter is an update on execution — and whether the AGI CPU opportunity is moving from “announced” to “real,” in a way that shows up in the financial model.
That distinction matters more than most summaries suggest. If Arm signals meaningful progress translating that demand into revenue (and the operational capacity to deliver), the forward revenue outlook changes materially. If updates are thin, the stock is likely to stay range-bound at best despite whatever the headline royalty numbers show.
The Valuation Problem Is Not Going Away
What’s interesting is that the bull case on Arm is genuinely compelling at the business level, but the math at the current price demands near-flawless execution for years. The stock’s GAAP P/E sits far higher than its non-GAAP multiple given the gap between GAAP and non-GAAP earnings.
Those are not small expectations. The challenge is that any guidance miss — even on the order of magnitude — tends to punish the stock hard. Last quarter, ARM fell sharply the day after reporting record revenue. The beat was real. The guidance nuances were not what the market wanted.
This pattern is worth sitting with. Arm has repeatedly traded down on beats. That is usually a sign of a stock where the bar is priced into the multiple before the report drops, and the market is looking for a reason to reprice expectations higher, not just confirmation of what is already modeled.
The Structural Case Is Strong
The underlying franchise is genuinely hard to compete with. Arm’s architecture underlies virtually every smartphone CPU sold globally. AWS Graviton, Google Axion, and Microsoft Cobalt are Arm-based. NVIDIA has announced “Vera,” a CPU design that will use Arm technology.
For fiscal 2031, the company has communicated long-term targets that include $15 billion in Arm AGI CPU revenue and $10 billion in IP revenue. And the royalty model is structurally superior — the contracts signed today create revenue that flows through the income statement years later, meaning the earnings growth pipeline has genuine visibility that most hardware companies cannot match.
Slight tangent that matters here: Arm is pursuing a strategic shift that changes its risk profile. Licensing IP is an asset-light, high-margin business. Building and selling chips — even AI CPUs — is not. Operating costs in Q4 reflected continued investment, and Arm has also highlighted sharply higher R&D spending year-over-year at the company level in fiscal 2026 as it invests in next-generation products like the Arm AGI CPU. The AGI CPU strategy is the right long-term move, but it introduces execution risk and margin volatility that was not present in the pure-IP model. At these multiples, the market is still pricing the higher-margin version of Arm. That tension does not resolve until the chip business proves its economics.
Technical Structure
ARM’s 52-week range runs from $100.02 to $452.70. The stock closed at $260.01, in the lower half of that range. Friday’s session saw a range of approximately $258.43 to $288.99, with the stock closing near the lower end — indicative of selling pressure heading into the report.
Key levels: $245 to $250 area as near-term support, $280 as the zone where momentum reasserts if the print is clean. A royalty revenue number near or above $700 million for Q1 would signal that data center growth and higher Armv9 royalty rates are fully offsetting weaker consumer end markets. That is the internal bull/bear dividing line on the royalty line.
Scenario Framework
Bull Case: Q1 royalty revenue hits $700 million or better, management announces clear progress converting Arm AGI CPU demand into shipped volume and revenue, and fiscal Q2 guidance comes in above the Street. ARM tests $310 to $330 in the session following the report.
Base Case: Revenue meets guidance around $1.26 billion, royalties grow around 20%, but the Arm AGI CPU update is incremental rather than decisive. Stock moves up modestly, 3% to 7%, but the near-term ceiling around $285 to $295 holds as the market waits for clearer contribution from the new silicon line.
Bear Case: Royalty revenue misses $680 million, guidance for Q2 is in-line or below, and Arm AGI CPU commentary is vague. Operating margin pressure surprises on the downside as costs accelerate. Stock tests $240 to $245 support. A close below $240 opens discussion about the $210 to $220 zone.
Active Trader Framework
The options-implied move is significant heading into the event. It reflects genuine uncertainty about whether the Arm AGI CPU strategy update will be additive or absent this quarter. Traders without a directional conviction should be aware that straddle premium can be expensive heading into Wednesday’s close. The risk is asymmetric in both directions: a clean beat with a credible Arm AGI CPU conversion story could compress the gap to the 52-week high quickly; a miss on guidance or margin would likely accelerate the selloff given how many investors bought the recovery from $100.
What matters most coming out of the earnings call is not Q1 revenue — that is largely set by guidance and easy to model. The number to watch is the royalty line versus the $700 million threshold, and the quality of CEO commentary on Arm AGI CPU execution for the back half of fiscal 2027. That is where the real information lives Wednesday night.
The franchise here is not in dispute. The question is always whether the stock is ahead of the fundamentals. Wednesday gives traders the next data point to answer it.
For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.
